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ABSTRACT
Tetrahydroquinolines (THQs) are a group of N-heterocyclic molecules derived from
natural sources. They show a wide range of interesting biological activity and have been the
basis for a variety of different medications including antibacterial and antiparasitic drugs. The
Hancock alkaloids, Galipinine, Galipeine, Cuspareine and Angustureine, are natural 1,2,3,4tetrahydroquinoline compounds that are found in the South American Angostura tree. Extracts
containing these alkaloids have been used to treat fever, dysentery and other ailments.
Interestingly, These compounds have shows in vitro antimalarial activity. However, it does not
appear in the literature that they have been evaluated for their potential antibiotic activity.
The synthetic utility of α-amino cycloalkylcopper reagents derived from tertbutylformamidines has not been extensively explored and a limited number of examples have
been reported in the chemical literature. It was hypothesized that the racemic Hancock alkaloids
could be synthesized using α-aminocycloalkyl cuprate cross-coupling chemistry as a synthetic
exercise to expand the utility of this class of cuprate reagents.
Initially the t-butylformamidine (TBF) functionalized tetrahydroquinoline (THQTBF) starting material was synthesized from 1,2,3,4-tetrahydroquinoline. This THQ-TBF was
treated with t-butyllithium to give the α-aminocarbanion which was reacted with a copper (I) salt
to form the α-aminocycloalkyl cuprate in situ. This cuprate reagent was then cross-coupled with
alkyl iodides, that corresponded to the requisite side chains of each alkaloid target to afford the
2-position functionalized THQ-TBFs. The TBF group was subsequently hydrolyzed to an Nformyl intermediate and then reduced to give the targeted Hancock alkaloids in good yields.
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Part I of this thesis briefly describes the discovery and medicinal history of the
Hancock alkaloids and how they are prevalent in modern medicine. Part II describes the
synthesis of TBF-THQ starting to produce the N-formyl THQ followed by treatment with
Meerwein’s reagent to afford the formamidine functionalized THQ. Part III describes the new
cuprate cross-coupling process used to produce the α-substituted THQ systems. Part IV describes
the removal of the TBF group through hydrolysis and lithium aluminum hydride reduction to
afford the target alkaloids.
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Chapter 1: Introduction
1.1 Background
In nature, the Rutacea plants of South America have functionalized the 1,2,3,4tetrahydroquinoline (THQ) core structure into various alkaloids called the Hancock alkaloids.
These include Angustureine, Cuspareine, Galipeine, Galipinine, structures seen in Figure 1.
These naturally occurring alkaloids have been exploited for their use in treating a variety of
deadly fevers and illnesses.1 Isolated in 2001, their THQ moiety was shown to be the core
structure that contributes to their antimicrobial, antifungal, and antiparasitic activity. Due to this
useful biological activity, these compounds have been used in the drug development of various
antibiotics.2 THQ derivatives are used to treat clostridium, streptococcus and salmonella
bacterial infections, Candida and Aspergillus fungal infections, and parasitic diseases such as
schistosomiasis.2,3 Many of the natural derivatives are heavily functionalized at the 2 position;
groups include alkyl and phenyl moieties. Further functionalization occurs at the 8 position and
includes alkyl and amino groups.

Figure 1: Structures for the four tetrahydroquinoline alkaloids, or Hancock alkaloids. The THQ
core is circled in red.
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1.2 Medicine
There are many different classes of antibiotics with various mechanisms of action. The
“floxacin” category includes broad spectrum antibiotics that work on both gram-negative and
gram-positive bacteria. They work by inhibiting the various topoisomerase enzymes found in
bacteria to stop DNA synthesis.3 The “floxacin” drugs all center on a quinoline-like core
structure. After isolating and characterizing the natural alkaloids, the core quinoline structure
was identified and functionalized to produce a range of antibiotics currently on the market such
as levofloxacin and ciprofloxacin seen in Figure 2. This biological activity has been reported for
hundreds of other tetrahydroquinolines (THQs).4 Many of these THQs have promising
pharmaceutical potential, such as 2-methyl-5-hydroxyl-1,2,3,4-tetrahydroquinoline which shows
strong analgesic action.5

Levofloxacin

Ciprofloxacin

Figure 2: Structure for levofloxacin and ciprofloxacin, two common antibiotic drugs. The
4(1H)-quinoline core can be seen circled in red.
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Figure 3: The center structure shows a modified THQ core and how that structure can be
functionalized into a variety of THQ derivatives.

Tetrahydroquinoline groups are also found in anti-malarial medications. For example,
various 8-aminoquinolines have shown strong anti-malarial activity including anti-relapse
potential. Malaria is relatively easy to treat but it often goes latent in certain cells. This appears
as a “relapse” weeks to months after the initial infection. Illustrated in Figure 4, these drugs
include primaquine and tafenoquine and are the only anti-relapse drugs currently on the market.
These compounds, along with the 4-methanolquinolines, work by inhibiting the degradation of
heme groups within the blood consuming parasites.6 Because of the wide array of biological
activity and promising antibacterial, antiparasitic and analgesic properties, the synthesis of these
THQ compounds have drawn considerable attention from medicinal chemists. A variety of
synthetic pathways for functionalized THQ compounds can be seen in Figure 3.
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Primaquine

Tafenoquin
e
Figure 4: Structure of two commercially available anti-parasitic quinoline drugs.
1.3 History/Precedent
The Hancock alkaloids have been synthesized through a variety of different methods as
reported in review papers.5,7 In this section three different examples will be illustrated to show
the different synthetic approaches. These syntheses are relatively recent methods for the
synthesis of both racemic and enantiopure Hancock alkaloids. These examples were selected due
to their current relevance and their unique synthetic approach.
Muñoz and co-authors describe an interesting method using a phase transfer mediated
Wittig olefination reaction8,9 and is shown in Scheme 1. The commercially available
quinaldehyde was reacted with the corresponding phosphonium salt via a Wittig reaction. This
was followed by hydrogenation to produce a racemic mixture of 3 of the Hancock alkaloids.
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Scheme 1: Muñoz8,9 et al. synthesis of the four THQ alkaloids.
Tao Yang and co-authors recently synthesized the four main Hancock alkaloids using
enantioselective asymmetric reductive amination (ARA).10 A scheme for this reaction can be
seen in Scheme 2. They utilize a chiral iridium catalyst to affect an asymmetric hydrogenation of
an iminium intermediate to afford chiral 2-substituted THQs.

Scheme 2: One pot intramolecular ARA for THQs and THIQs. Tao Yang10 et al.
Lastly, Davies et al. (2018) have published papers and a recent review detailing the
synthesis of these four enantiopure Hancock alkaloids from simple starting materials.7,11,12 Seen
in Scheme 3, Davies proposes a multi-step process starting with 3-(o-bromophenyl)propanol
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which is commercially available. Davies first utilizes a one-pot Swern oxidation/Wittig reaction
of A using I as the ylide to afford B as a single diastereoisomer in 78% yield. This was followed
by the conjugate addition of II to afford C as a single diastereoisomer in 80% yield. Subsequent
treatment of C with formic acid in the presence of Et3SiH produced D in 81% yield. Treatment
of D with Pd(OAc)2 along with Xphos and Cs2CO3 in toluene at reflux for 24 h gave THQ E in
quantitative yields via a cyclic amination reaction. III was prepared by treating o-tertbutyldimethylsilyl-5-bromoguaiacol with n-BuLi to produce the corresponding aryllithium
reagent. E was added to III to afford ketone F after workup, which was isolated in 88% yield.
Treatment of F with LiAlH4 and TFA in the presence of Et3SiH gave G in 50% yield. Treatment
of G with Pd/C in aqueous formaldehyde under an atmosphere of hydrogen resulted in
hydrogenolytic N-debenzylation and reductive N-methylation, giving H in 57% yield.
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Scheme 3: Davies7 et al., multistep process illustrating the asymmetric synthesis of Galipeine.
This multistep synthesis is certainly the most complex of the three methods reported and
demonstrates the synthesis using inexpensive 3-(o-bromophenyl)propanol starting material.
These methods offer unique pathways to produce the desired chiral and achiral Hancock
alkaloids. These syntheses could be improved upon by reducing the number of steps and
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therefore the efficiency of the overall process. The synthesis detailed in this thesis is a 5-step
synthetic process that does not use expensive palladium catalysts but instead focused on an αaminocycloalkyl carbanion approach to produce the racemic Hancock alkaloids.
Although the Hancock alkaloids have been synthesized through a variety of methods8-12,
they have not been made using an α-amino cycloalkylcopper cross-coupling methodology. The
goal of this project was to synthesize the four Hancock alkaloids via these underutilized αaminoalkyl cuprate reagents.
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1.4 Cuprate Precedent
Organocopper chemistry gradually arose during the 1950’s with the synthesis of various
organocopper reagents such as phenyl copper prepared by Reich and dimethyl copper prepared
by Gilman.13 Gilman went on to synthesize the first dimethyl cuprate reagents seen in Scheme 4.

Scheme 4: Generic use of a simple dialkyl cuprate or Gilman reagent.
These discoveries led to breakthroughs and rapid advancement in cuprate cross-coupling
chemistry. First the conjugate addition reactions were explored by Kharasch and House et al. and
provide a method for the synthesis of countless compounds.14,15 Corey and Posner then reported a
variety of substitution reactions using these copper ligands to cross couple simple nonfunctionalized alkyl groups for natural product syntheses.16,17 These reactions are depicted in
Scheme 5.

Scheme 5: Scheme illustrating the cuprates from Corey16 and Posner17 et al.
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When using dialkyl cuprates, only one of the alkyl groups undergoes transfer to the
carbon electrophile. Because of this limitation, heteroalkylcuprates were soon discovered to
overcome this inefficiency. The heteroalkyl group is referred to as the non-transferable or
residual ligand and allows for the conservation of the transferable ligand. Alkynyl groups can
also be used as non-transferable ligands in these types of cuprate reactions. Despite earlier
reports of silylcopper and stannylcopper reagents, the development of synthetic applications for
these reagents was reported by Fleming and Piers and allow for a wider range of synthetic
potential.18,19 These were used similarly and allowed for much greater regiocontrol and
stereocontrol of the desired products seen in Scheme 6. Developments in the cuprate production
led to new cuprate syntheses. The original production involving the use of organolithium and
Grignard reagents limited the types of transferable groups. Transmetalation from different
transition metal organometallic reagents to copper salts allow for highly functionalized groups to
be transferred.

Scheme 6: Scheme illustrating an example of both silyl A and stannyl cuprate B20
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Lithium α-aminoalkylcuprates offered another useful expansion of the field of αheteroatom alkyl cuprates. The first reported examples of sp3 coordinated α-aminoalkylcuprates
came from Myers and co-workers, using dipole-stabilized α-amino carbanions. Scheme 7
illustrates the α-aminocycloalkyl cuprate, derived from a α-lithiated N-tert-butyl formamidine of
2-piperideine with allylbromide in a substitution reaction.21-25

Scheme 7: α-Amino alkylation using a mixed α-aminocycloalkyl cuprate reagent, Myers23 et al.,
Dieter and Alexander were the first to report α-aminoalkylcuprate conjugate additions
derived from α-amino carbanions derived from tert-butyl formamidine derivatives and tert-butyl
carbamates (N-Boc). α-Aminoalkylcuprates prepared from copper iodide, copper thiophenylate
and α-lithiocarbamates gave moderate yields of α-amino ketones.26,27 Excellent yields were
obtained when using cyanocuprates (2RLi + CuCN) reagents although these cuprate reactions
were more sensitive to steric effects. A scheme illustrating the higher order cyanocuprates can be
seen in Scheme 8.
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Scheme 8: Dieter et al., sample reactions showing the use of α-amino cycloalkylcyanocuprates27
derived from α-lithiated formamidines and carbamates in conjugate additions to enones.

Overall, cuprate chemistry offers a powerful tool for the formation of new C-C bonds and
the precedent for cuprate cross-coupling reactions and reagents goes back almost one hundred
years.28 Organocopper chemistry is a great tool for functionalizing the α-position of secondary
amines and for this reason was chosen as the best way to synthesize the Hancock alkaloids.
1.4: Goals
The goals for this research include the total racemic synthesis of Galipinine, Galipeine,
Angustureine and Cuspareine from 1,2,3,4-tetrahydroquinoline starting material using a new
synthetic approach to prepare these alkaloids and an expansion of α-aminoalkyl cuprate
chemistry. The organometallic reagent derived from TBF-THQ will be used to functionalize the
tetrahydroquinoline at the 2 position to afford the target alkaloids. A general scheme of this can
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be seen in Scheme 9. Lastly, all the targets and select intermediates will be tested using
inhibition disc assays tests to evaluate their antimicrobial efficiency because we are not aware of
the Hancock alkaloids being tested for antibiotic properties.9 These four naturally occurring
alkaloids are good first targets because they offer a baseline for natural antibiotic, antiparasitic
and antifungal activity. Select synthetic intermediates and derivatives will be compared to a
known antibiotic control compound.

Scheme 9: General scheme for the synthesis of 2-substituted tetrahydroquinolines.
A proposed retrosynthesis for the Hancock alkaloids is illustrated in Scheme 10. First
1,2,3,4-tetrahydroquinoline will be functionalized with a t-butyl formamidine (TBF) group. This
will direct metalation to the 2 position and will allow for alkylation with a haloalkane or
pseudohaloalkane. Lastly the directing group will be hydrolyzed, and the nitrogen methylated to
produce the final compound.
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Scheme 10: Retrosynthesis of the Hancock alkaloids.
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Chapter 2: Preparation of Formamidines
2.1 Objective
Our approach involved the efficient synthesis of the TBF functionalized
tetrahydroquinoline 9. (Scheme 11). The TBF group allows for directed deprotonation and
subsequent metalation of the acidic α-protons through pi-orbital stabilization.28 For this reason,
functionalization of the α-amino position of the THQ structure can be achieved in good yields.
2.2 Preparation of TBF tetrahydroquinoline
The most common way to produce amidine functionality is through the condensation of a
carbonyl intermediate with an amine. Method A (Scheme 11) illustrates the synthesis of the Nformyl THQ derivative 10 by reacting ethyl formate, an acid catalyst, followed by treating 10
with triethyloxonium tetrafloroborate and t-butylamine to afford the t-butyl formamidine
functionalized tetrahydroquinoline 9. This synthesis closely follows the Myers et al. procedure.22

Scheme 11: THQ-TBF synthesis using Method A, a two-step synthesis using Meerwein’s
reagent.
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A more recent procedure by Myers et al. involved the direct trans-amidation of piperidine
and pyrrolidines and this method was adapted for this project.29 THQ 11 was reacted directly
with N,N-dimethyl-N-t-butyl formamidine 12 and an acid catalyst in toluene to afford the TBFTHQ 9 (Scheme 12).

Scheme 12: THF-THQ synthesis using Method B, a single step synthesis to produce the TBF
functionalized THQ compound.

Both methods A and B were explored. Purification of amidines was difficult because the
amidine functionality is basic and was easily hydrolyzed in the presence of aqueous conditions
making column chromatography problematic. Treating silica with triethylamine can help reduce
the acid-base interaction minimizing hydrolysis and improving purification success by column
chromatography.
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2.3 Results of N-formyl THQ production for Method A
The synthesis results of TBF-THQ for method A are illustrated in scheme 11 and Table 1.
The reactions were carried out in oven dried glassware under anhydrous nitrogen. Using the
distilled ethyl formate, formylation reaction compound 10 was synthesized in 84% yield after
purification. Only the p-toluenesulfonic acid (p-TsOH) catalyst was able to produce the desired
product 10 in good yields. Other catalysts such as sulfuric acid and triflic acid (TfOH) did not
produce any desired product 10 (Table 1) The reaction worked best when ethyl formate was used
as the solvent. Attempts using a high boiling point solvent such as toluene or xylene and
stoichiometric ethyl formate resulted in significantly lower yields than when ethyl formate was
used as the solvent. Reactions were monitored through TLC. After distillation the product slowly
crystalized into a bright white powder and was stable at rt conditions indefinitely.

Scheme 13: Scheme illustrating N-formylation attempts.
Trying to make 10 directly through the hydroformylation of quinoline was also attempted
using a procedure from Torok, Giantatassio, Kulkarni.30 The formic acid and Pd/C produced a
mixture of products and had very low yields in this project. Reaction yields increased over time
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but seemed to stall around the third day. Reaction times longer than 72 h did not produce
appreciable increases in yields for either the ethyl formate or formic acid formylation.
Table 1: Optimization of formylation methodology
Entry

Catalyst

Solvent

Temp/Time (h)

%Yield

1

-

ethyl formate

15

2

TfOH
15% mol
H2SO4
15% mol
pTsOH
15% mol

ethyl formate

reflux
24
reflux
24
reflux
24
reflux
24

5

pTsOH
15% mol

ethyl formate

reflux
48

76.8

6

pTsOH
15% mol

ethyl formate

reflux
72

84

7

pTsOH
15% mol

reflux
48

45

8

pTsOH
15% mol

toluene
(1 eq ethyl
formate)
xylene
(1 eq ethyl
formate)

reflux
48

35

3
4

ethyl formate
ethyl formate

0
0
50

Overall, the N-formyl THQ synthesis was successful and produced the desired compound
(10) in 84% yield despite the long reaction times. Purification was carried out by first column
chromatography using 50:50 hexane:ethyl acetate then by bulb-to-bulb vacuum distillation to
afford a white crystalline solid that was characterized by NMR.
2.4 Synthesis of TBF-THQ for Method A
Method A as seen in Scheme 11, from the N-formyl THQ 10, the TBF-THQ 9 was
prepared through treatment with Meerwein’s reagent ([Et3O+][BF4-]) and t-butylamine at reflux
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in DCE. First, the Meerwein’s reagent was prepared in situ using boron trifluoride etherate and
epichlorohydrin in dry diethyl ether. The triethyloxonium tetrafluoroborate crystals were added
immediately without direct isolation under N2 atmosphere to the N-formyl THQ and heated to
reflux overnight followed by the addition of t-butylamine to afford the TBF functionality. This
reaction produces an alkylated N-formyl intermediate that is subsequently condensed with the tbutylamine releasing ethanol as a side product to afford the TBF-THQ 9. Reaction completed in
24 h determined by TLC analysis. Purification using column chromatography using 93:7
hexane:triethylamine as the eluent followed by vacuum bulb-to-bulb distillation afforded a pure
colorless oil in 75% yield; purity was determined by NMR. The formation of the TBF-THQ 9
compound from the N-formyl THQ 10 adapted from Myers et al. was achieved in good yields
(65-75%) after purification.22 Further optimization was not required.
2.6 Synthesis of transamidation process from Method B
As seen in Scheme 12, Method B was an alternate approach to prepare the TBF-THQ 9. It
involved the transamination of N-N-dimethyl-N-t-butyl formamidine 12 with 1,2,3,4tetrahydroquinoline 9 using an acid catalyst to afford THQ-TBF 9. In this reaction the THQ
nitrogen acts as a nucleophile and therefore reaction rates are dependent on the strength of the
nucleophilic ability of the THQ 11. Other more basic secondary amines such as piperidine are
known to have high yields using the transamination procedure from Myers et al.29
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Table 2: Optimization of the transamination methodology, Method B.
Entry

Catalyst/mol%

Solvent
(bp, °C)

Temp/Time
(h)

Yield %

1

NH4SO4
0.05

DCM (39.6)

reflux
24

0

2

NH4SO4
0.05

hexane (68)

reflux
24

0

3

NH4SO4
0.05

ethyl acetate (77)

reflux
24

0

4

NH4SO4
0.05
NH4SO4
0.05

toluene (111)

rt
24
reflux
24

0

6

NH4SO4
0.05

toluene (111)

reflux
48

20

7

NH4SO4
0.05

toluene (111)

reflux
72

38

8

NH4SO4
0.05

xylene (139)

reflux
24

25

9

NH4Cl
0.05

toluene (111)

reflux
24

0

10

TfOH
0.05

toluene (111)

reflux
24

0

11

pTsOH
0.05

toluene (111)

reflux
24

0

12

Zn2OTf
0.05

toluene (111)

reflux
24

0

13

Sc3OTf
0.05

toluene (111)

reflux
24

0

5

toluene (111)

10

2.7 Results of trans-amination, Method B
The formation of the TBF-THQ 9 from the THQ 11 was accomplished in moderate yields.
After purification by distillation, the yields ranged from 10-38% for method B. Best results were
obtained with 72 h of reflux using toluene and gave yields of 38%. Yields above 40% were never

32
obtained regardless of the conditions. A variety of catalysts and solvents were explored, and the
results varied based on the different catalysts. When using NH4Cl, pTsOH, TfOH, Zn2OTf and
Sc3OTf little to no product formation was seen. When using ammonium sulfate, product
formation was seen in modest yields. A moderately high boiling point solvent such as toluene
was required for the reaction to proceed. It is unknown why xylene did not produce similar
yields to the toluene with similar reaction times. The xylene was not taken from a solvent
purification machine like the toluene and instead was distilled. Water contamination could have
reduced product formation. Interestingly, polar solvents such as ethyl acetate more easily
dissolved the NH4SO4 catalyst but did not increase yields. As the reaction time increased past 72
h product formation slowed and the hydrolyzed side product N-formyl THQ appeared, most
likely from water contamination from the NH4SO4 or TBF 12.
2.8 Conclusion
Overall, both procedures are viable for production of the TBF-THQ 9. Despite the Myers
procedure being a two-step process and taking an additional 72 h, the 70-80% yield and more
consistent results make it a better process to produce the TBF-THQ. Purification posed a
significant challenge due to the TBF moiety water sensitivity. In the presence of trace amount of
water, TBF would hydrolyze to the corresponding N-formyl group. Purification included column
chromatography using 93:7 hexane:triethylamine as the eluent followed by vacuum bulb-to-bulb
distillation at reduced pressure. Even when using a depolarized silica column, significant
hydrolysis was seen during the purification. Pure product was stored over calcium carbonate to
limit hydrolysis.
The production of TBF-THQ 9 was achieved successfully with yields up to 80% using
method A. Due to the low nucleophilicity of the THQ starting material, the transamination
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pathway is inadequate for efficient conversion of THQ to N-formyl THQ and therefore the 2-step
approach (Method A) was used to produce the bulk of the TBF starting material 9.
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Chapter 3: Synthesis of Tetrahydroquinoline Alkaloids
3.1 Objective
The Hancock alkaloids Angustureine, Galipinine, Cuspareine, Galipeine and other αsubstituted tetrahydroquinoline compounds have shown a variety of biological activity and are
therefore useful synthetic targets. Several published papers describe the complete synthesis of
these alkaloids from various starting materials.5,7 The aim of this project was to develop an αaminocyclo alkyl cuprate procedure capable of functionalizing the alpha position of the
tetrahydroquinoline starting material into the Hancock alkaloids. Quinoline, tetrahydroquinoline,
and indole systems have been studied and α-functionalization has been reported by Myers et al22;
however, the Hancock alkaloids have not been synthesized using α-aminocarbanions or αaminocycloalkyl cuprates
3.2 Cuprate cross-coupling
Previous research from the lab of A. I. Myers have shown various cyclic amines,
including 1,2,3,4-tetrahydroquinoline, can be functionalized at the 2 position by employing the
use of t-butyl formamidine (TBF) moiety as a dipole stabilized directing group for preparing the
α-amino carbanions.22 This carbanion will subsequently metallate with 1-pentynyl copper to
afford the mixed α-aminocycloalkyl cuprate which was reacted with an alkyl halide electrophile
as illustrated in Scheme 14.
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Scheme 14: Tetrahydroquinoline alkylation, where n = 2, (97% yield).
Myers et al. has shown the t-butyl formamidine substituted tetrahydroquinoline favors
dipole stabilized metalation at the 2 position due to increased anion stability from the
formamidine nitrogen.22,31 It is generally agreed that the deprotonation of these systems requires
the hydrogen to be nearly orthogonal to the π-system of the formamidine group.29 This increased
stability allows for directed metalation and substitution using a variety of electrophiles. By
employing this directing group and by controlling the conditions of the anion production various
2 substituted 1,2,3,4-tetrahydroquinoline systems can be produced.
Myers et al. reported a problem with many of the weaker electrophiles such as 1iodobutane and allyl bromide. These electrophiles most likely proceed via complex free radical
intermediates and favor elimination products over substitution products.22 This effect is seen
when electrophiles such as 1-iodiobutane are directly added to the α-aminocarbanion. To resolve
this problem, non-transferable α-aminoalkylcuprate was employed to facilitate cross coupling
while reducing the competing elimination reaction.
Based on the α-aminocycloalkyl cuprate precedents developed by the research
laboratories of Meyers and Dieter, it is theorized this type of TBF directed α-aminoalkyl cuprate
chemistry will be a viable approach to synthesize the Hancock alkaloids. The key step of the
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alkaloid synthesis will be the coupling of TBF-THQ 9 with the corresponding halo-R-group to
alkylate the α-THQ-TBF position.
3.3 Synthesis of alkyl iodides for the requisite Hancock alkaloid side chains
The synthesis of the bromo R-groups (14-17) and iodo R-groups (18-21) required for target
alkaloid production was achieved in excellent yields following a modified Appel reaction32,33
(Scheme 15-16). The starting alcohol was reacted with N-bromosuccinimide (NBS) and
triphenylphosphine in DCM to afford the brominated intermediates 14-17 in excellent yields,
95%, as a colorless liquid.

Scheme 15: Synthesis of R-Br targets for subsequent iodination.
To produce the iodine target a simple Finkelstein reaction was utilized. The bromointermediates 14-17 were combined with excess potassium iodide and heated to reflux in acetone
for 24 h to afford the crude iodine targets 18-21. The product was filtered and passed through
silica gel (20 g) using 80:20 hexane:ethyl acetate to afford an off-white solid. This was then used
directly in the cross-coupling reactions.
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Scheme 16: Synthesis of R-I targets for cross coupling cuprate reactions.
The procedure for the alkyl halide 20 was adapted, in parts from the work of Bovicelli et
al. seen in Scheme 17.34, 35 Producing the iodine starting material 20 required a multistep process
because the corresponding alcohol was not available commercially. A scheme illustrating the
process can be seen in Scheme 17. Tyrosol 22 was purchased commercially and brominated
using KBr and oxone in acetone at -10 °C to afford the o-bromo tyrosol 23 with minimal
dibrominated side product. Methoxylation was achieved using an adapted procedure from
Brandsma et al. producing the methoxy tyrosol 24.36-39 The methoxylation proved difficult and
required significant method development. Other copper salts such as CuI were found to be
unsuccessful, producing low yields. Purification was also challenging because column
chromatography gave poor separation of the target from impurities regardless of the eluent. The
modified Appel reaction using NBS and PPh3 in DCM was used to brominate the primary
alcohol to make 25 followed by a silyation of the phenolic group using tert-butylethylsilyl
chloride (TBDMS-Cl) and imidazole to produce 26 in good yields. Lastly the same halogen
exchange reaction using KI in acetone was employed to form the iodo compound 27 in good
yields.
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Scheme 17: Reaction scheme for the synthesis of alkyl iodide 27 required to synthesize
Galipeine.

3.4 Copper ligand
Choosing the right type of copper salt for a cuprate reagent is important and can
drastically change the results of a reaction. If starting material is difficult to obtain, using mixed
heterocuprates with non-transferable R-groups is often the best option. Meyers et al. and Dieter
et al. explored the use of mixed cuprate reagents with non-transferable R-groups in the
functionalization of various secondary amines including indole and tetrahydroquinoline systems
(Scheme 14). Meyers et al. chose to use 1-pentynyl copper as the cross-coupling copper reagent
with great success.25 Dieter opted for copper thiophenylate and copper cyanide/lithium chloride
and reported success with α-amino alkylation using these copper reagents. In theory, all hetero-
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nontransferable R-group-type cuprate reagents should be capable of producing cross-coupled
product using the right conditions. In practice, the non-transferable group appears to play a
significant role in the success of the cross-coupling because it may affect the complex
aggregation state of the cuprate or the electronic state of the cuprate reagent.

Scheme 18: General scheme for α-aminocycloalkyl cuprate methodology leading to the
Galipinine target.
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Table 3: Cuprate method optimization (Scheme 17)
Entry

Ligand/eq

Solvent

R-I (21)

Yield %

THF

Max
cuprate
temp °C
-30

1

-

I

<10

2

CuSPh (1.5)

THF

-30

Br

0

3

CuSPh (1.5)

THF

0

Br

0

4

CuSPh (1)

THF

-30

OTf

0

5

CuSPh (1)

THF

0

I

5

6

THF

-30

Br

0

THF

-30

I

5

8

Cu 2-phenyl
acetylene (1)
Cu 2-phenyl
acetylene (1)
CuCN (1)

THF

18

Br

0

9

CuCN (1)

THF

18

I

0

10

CuI/1-pentyne
(in situ) (1)
CuI/1-pentyne
(in situ) (1)
1-Pentynyl Cu
(1)
1-Pentynyl Cu
(1)
1-Pentynyl Cu
(1)
1-Pentynyl Cu
(1.5)
1-Pentynyl Cu
(1)
1-Pentynyl Cu
(1)
1-Pentynyl Cu
(1)

THF

0

I

0

THF

18

I

0

THF

-78

I

0

THF

-40

I

0

THF

-25

I

40

THF

0°

I

57

THF

18

I

64

THF/Ether

-30

I

0

THF/Ether

0

I

>10 mixed

7

11
12
13
14
15
16
17
18
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3.5 Optimization and results of cuprate methodology
As seen in Table 3, five different copper salts were explored. Four were heterocuprates
and used non-transferable copper ligands. Only the 1-pentynyl copper gave any useful amount of
product. The cuprate reaction using 1-pentyne was optimized using 1-pentynyl copper as the
CuX source and the results can be seen in Table 3. The direct alkylation of the TBF-THQ
carbanion, Entry 1, generated by treatment with 1 eq t-BuLi, and iodine starting material
afforded very low yields, ̴ 10%. Determined by NMR, the unpurified reaction mixture contained
~90% starting material or side products and very little alkylated product. The side products
appeared to be caused by the elimination and transmetallation product from the alkyl iodide 21.
These side products were not isolated and fully characterized to overcome this challenge a
variety of cuprate reaction conditions and were tried in effort to prevent these side products from
forming.
Optimization of the cross-coupling procedure included systematically varying the CuX
and THQ-TBF equivalencies, rxn times, and temperatures of each step to form the targeted
product (28) in the best yields. Firstly, the amount of copper reagent and t-butyl lithium was
reduced to stoichiometric amounts (Entry 4-5). This changed the cuprate complex characteristics
and made it easier to visualize complete cuprate formation. Next, different copper (I) sources
were tested to produce the desired targets. Preparing the heterocuprates from copper
phenylacetylene, and copper thiophenolate were attempted first. Copper thiophenolate was
unable to produce any desired product 28 when using the alkyl bromides or the alkyl triflate
(Table 3 Entry 2-4). Changing the temperature had no effect on product formation. The copper
thiophenolate, Table 3 Entry 5, was able to produce small amounts of desired cross-coupled
compound 28 when coupled with alkyl iodides but yields were still extremely low, ~5%. Copper
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2-phenylacetylene showed similar results. When coupled with the alkyl bromide, shown by
Table 3 Entry 6, no product was seen. In Table 3 Entry 7, coupling with the alkyl iodide showed
product 28 but in very small amounts, ~5%. Next, copper cyanide was used as the copper source.
Despite using higher temperatures (0 oC – 18 °C), neither the alkyl bromide nor the alkyl iodide
produced any measurable cross-coupled product 28 (Table 3 Entries 8-9). Because the alkyl
iodides were the only electrophile that produced the desired product 28, they were used as the
electrophile for the remainder of the optimization methodology. A few attempts to generate the
1-pentynyl copper reagent in situ can be seen in Table 3, Entries 10-11. These attempts yielded
no desired product at 0 oC or at 18 °C. 1-Pentynyl copper was the final copper reagent used in
the optimization. Experiments were carried out to find conditions that were able to produce the
desired compound 28 in good yields. The most notable conditions using 1-pentynyl copper can
be seen in Table 3 Entries 12-18. The idea that cuprate decomposition could be playing a role in
the failure of the reactions led to low cuprate temperatures (-78 °C) being used first, shown in
Table 3 Entries 12-13. These experiments yielded no measurable product 28. Next, attempts
allowing the cuprate suspension to warm (-25 °C) produced the first good yield (40%) of crosscoupled product 28 shown in Table 3, Entry 14. Because of this success, this warmer cuprate
method was adapted on and experiments using higher temperatures were attempted. As seen in
Table 3 Entries 15-16, cuprate suspensions warmed to 0 °C and 18 °C produced the highest
yields yet, 57% and 64% respectively. As a final thought, experiments using mixed THF/ether
solvents were attempted using the same conditions as the previous successful reactions shown in
Table 3 Entries 17-18. Several attempts were interesting and produced at least 4 formamidine
proton signals in 1H NMR spectra suggesting possible cross-coupling products. It is not
understood why the ether solvent promoted other cross-coupling products.
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Using these optimized conditions, the reaction of TBF-THQ 9 with different alkyl iodides
to produce the Hancock alkaloids was examined (Scheme 19). The cuprate coupling reactions
afforded each of the α-substituted TBF-THQ (28-31) alkaloids in moderate yields. The relative
size of the coupled group appeared to decrease overall yields when compared to the yields
reported by Meyers (~91%) using the 1-butyl and methyl iodide electrophiles. All explored alkyl
iodides in this project series behaved similarly within the cross-coupling reaction and gave yields
ranging from 50-64%.

Scheme 19: Cuprate promoted alkylation of TBF-THQ 9
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3.6 Discussion
The copper complexes were extremely sensitive to moisture and trace water
contamination especially during high humidity days. Cuprate decomposition was seen as a nonhomogenous or dark black solution. The quality of the t-BuLi seemed to also play a significant
role in the success of the reaction. Older t-BuLi bottles or bottles with multiple needle punctures
slowly degraded, seen as white precipitate on the bottom of the bottle. This mildly degraded tBuLi was not suitable for cuprate formation and would lead to cuprate non-homogeneity and a
failed reaction. Best results were seen using a fresh bottle of t-BuLi but success continued for at
least 30 days using the same bottle as long as regular titrations were completed.
1-Pentynyl copper was insoluble in hexane, toluene, chloroform, ethyl aceate and DCM.
With proper cuprate formation the copper complex fully dissolved and formed a homogenous
gold/brown solution. This homogeneity was used to determine the status of the cuprate and
whether it was fully formed or not. The most notable change in the optimization methodology
was the increase in temperature of the cuprate suspension. Bringing the cuprate suspension
temperature above 0 °C was not attempted until countless failed experiments at lower
temperatures. Upon reaching 10 °C, the reaction notably changed in color and opacity and this
indicated complete cuprate formation. In the successful experiments (see Table 3, Entries 14-16)
complete cuprate formation was seen. Examples of a failed non-homogenous (A) and successful
homogenous (B) cuprate cross-coupling experiment can be seen in Figure 5. The complete
cuprate homogeneity was seen at 45 minutes between 5 and 10 °C. If the cuprate was stirred any
longer than 70 minutes, cuprate decomposition was seen and product yields decreased. Any
attempt using cooler temperatures, between -78 to -30 °C would results in no product formation
(see Table 3, Entries 12-13).
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A

B

Figure 5: (A) Cold, non-homogenous failed cuprate experiment. (B) Warm, homogenous
successful experiment
Furthermore, the cuprate solutions were sensitive to solvent concentration. The first few
attempts (not shown in Table 3) used 10 mL THF per mmol and no product 28 was seen. The
cuprate formation worked best when 6 mL THF per mmol was used. The THF had to be either
freshly distilled or freshly dispensed from a solvent purification apparatus. Even solvent stored
under nitrogen for 24 h was not suitable for cuprate formation due to suspected water
contamination. Using the warm cuprate method yields between 60-64% were obtained after
vacuum bulb-to-bulb distillation and column chromatography.
The cuprate cross coupling process was sensitive and difficult to control due to the large
number of variables. Slight variations in timing, temperature, solvent amount, and quality of the
reagents would either cause success or failure. For this reason, the majority of the time spent
optimizing the Hancock alkaloid synthesis was focused on the cuprate chemistry optimization.
The cross-coupled products (28-31) were produced in good yields (50-64%) after much
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optimization. Purification proved difficult due to the tendency of the TBF to decompose on
silica, however, it was easily remedied by using vacuum bulb-to-bulb distillation. The higher
molecular weight products 28-31 were easily separated from the TBF-THQ and alkyl iodide
starting materials through this type of distillation.
Overall, the cross-coupling procedure developed was effective in the production of the core
structure of the targeted alkaloids Angustureine, Cuspareine, Galipeine, Galipinine. The αaminocycloalkyl cuprate chemistry proved to be challenging due to the sensitivity of the cuprate
reagent to slight changes in stoichiometry and temperature. Changes in temperature drastically
altered the side product potential and, in some cases, produced entirely the wrong product or no
product at all. With careful experimentation, conditions that favored the α-substitution of the
THQ-TBF starting material were successfully achieved.
3.7 Conclusion
In summary, the developed α-aminocycloalkyl cuprate method using 1-pentynyl copper
as a non-transferable group in reaction with alkyl iodide electrophiles apperars to work well with
a variety of alkyl iodides. This method uses 1-pentynyl copper in stoichiometric amounts and is
therefore more efficient than the Meyers procedure which used 2 eq CuX. However, when
compared to the butyl system reported by Meyers25, et al. yields were lower than their reported
91%. This may be due to the size of the alkyl iodide chosen for coupling or the need for large
excess of cuprate to alkyl halide to increase product yield. For this project, all the TBF-THQ
alkaloids were successfully synthesized in moderate yields using α-aminocycloalkyl copper
reagents. Cuprate methodology may benefit from further studies into cuprate control using
higher molecular weight alkyl iodides.
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Chapter 4: Hydrolysis and Reduction of Coupled Formamidine Derivatives
4.1 Introduction
After the cuprate coupling procedure, the final steps required to produce the target
alkaloids involved the conversion of the TBF group to a methyl group. Most literature
procedures from Meyers et al. involved the complete removal of the TBF group using ethanol
and potassium hydroxide or hydrazine followed by the alkylation of the secondary amine with
methyl iodide.25 This process can be harsh due to the strong base and may result in overalkylation of the nitrogen, although this was not reported. Additionally, hydrazine is highly toxic
and potentially carcinogenic. For this reason, a milder method was developed. This approach for
the final N-methyl alkaloids used an aqueous hydrolysis to give an N-formyl intermediate
followed by LiAlH4 (LAH) reduction of the N-formyl intermediates.
4.2 Hydrolysis of the t-butyl formamidine moiety
Formamidine production can be thought of as imine condensation which requires the
removal of water to form the imine product. For this reason, it is reasonable for the TBF
hydrolysis to be successful using a simple water reflux. This idea was employed to produce the
N-formyl derivatives of the coupled alkaloids. Multiple hydrolysis attempts using a variety of
bases and temperatures resulted in complete removal of the TBF group, replacing it with a single
hydrogen. This reaction may be useful in some circumstances, but a more straightforward
method included the conversion of the TBF group into a formyl group. This was done by a
simple reflux with water for 24-48 h while monitoring by TLC. After the 48 hours the reaction
was extracted using DCM, dried and concentrated to afford the N-formyl alkaloids 34-37 in
excellent yields (Scheme 20).
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Scheme 20: Scheme for the hydrolysis of the TBF to the N-formyl
Table 4: TBF hydrolysis to the N-formyl methodology for 34
Entry

Base

Solvent

N-CHO

N-H

Yield %

1

-

H2O

90

0

90

2

-

H2O/DMSO

80

0

80

3

K2CO3

H2O

40

45

85

4

KOH

H2O

0

90

90

5

NaOH

H2O

0

89

89

4.3 Results of formamidine hydrolysis
The hydrolysis of the TBF group was easy and straightforward and the results can be
seen in Scheme 20 and Table 4. Simply heating H2O and reflux gave the N-formyl derivatives
34-37 in high yields, ̴ 90% (see Table 4 Entry 1). The insolubility of the alkaloids in water was
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the most limiting aspect of the reaction, however, even the most insoluble TBF alkaloid was
hydrolyzed after 48 hours of reflux. DMSO was added in entry 2 to increase solubility of the
TBF alkaloid but after many attempts was found to be not needed and may decrease yields by
lowering extraction efficiency. Adding a base to the reaction gave either a mixture of N-formyl
and N-H products (see Table 4 Entry 3) or converted the TBF to the N-H completely (see Table
4 Entries 4-5). All four TBF alkaloids, 34-37, were hydrolyzed without difficulty and in
excellent yields using boiling H2O at reflux. Purification of 34-37 was important to make
subsequent N-methyl purification easier. First, column chromatography was carried out using
80:20 hexane:ethyl acetate followed by reduced pressure distillation to afford the 34-37 in good
to excellent yields, 80-95%.
4.4 Results of N-formyl alkaloid reduction
The reduction of the N-formyl alkaloids was relatively straightforward. A simple
procedure using LiAlH4 in THF was used Scheme 21). Optimization included increasing the
LiAlH4 to 2-5 equivalencies and increasing reaction temperatures to reflux. All the N-formyl
compounds 34-37 were converted to the corresponding methyl groups in excellent yields using
this method.
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Scheme 21: Scheme for the reduction of the N-formyl intermediates, Angustureine, Cuspareine,
Galipeine, and Galipinine.
4.5 Discussion
The hydrolysis procedure required 24-48 h of reflux (Scheme 20) and provided an
excellent way to convert TBF into formyl compounds if no other water sensitive groups were
present, with ~90% yield. The side product t-butylamine was easily removed during distillation
and the N-formyl THQs (34-37) were purified using column chromatography and distillation.
This method offers an alternative to the harsher hydrazine or KOH methods and the potential for
side reactions is low. The LiAlH4 reduction was also a straightforward process that required 24 h
reflux and worked well with excess LiAlH4 and high temperatures.41 All four N-formyl
intermediates, 34-37, were treated with 2 eq LiAlH4 in THF and heated to reflux for 24 h to
afford 1, 2 and 4 in good yields (Scheme 21). These final methyl targets 1, 2 and 4 were stable at
rt and stored in brown vials without obvious decomposition. The final alkaloids 1-2 and 4 were
submitted for combustion analysis (C, H, N) to assess their purity.
4.6 Conclusion
Overall, the production of 1, 2 and 4 was achieved using a 3-step novel approach. The
hydrolysis step was a simple water reflux that afforded 34-37 in excellent yields, ̴ 90%. We have
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proven that TBF functionality can be easily converted to the corresponding amides in excellent
yields without the potential for side reactions using deionized water. This method appears to be
tolerant of ether functionality and may also be tolerant to carbonyl-containing groups. Reduction
of amides using LiAlH4 is a well-known process, however, a competing dealkylation reaction
was observed with the LiAlH4 reduction at room temperatures.34 For this reason, very dry
conditions, excess LiAlH4, and reflux temperatures were required to produce the N-methyl
alkaloids chemoselectively and in good yields. The LAH reduction worked well regarding 34-37
under the right conditions. It is unknown why the reduction produced dealkylated products at
lower temperatures. Using dry THF and reflux conditions crude yields were between 90-95%
and, after column purification and distillation, yields were between 80-85% for 1-2 and 4. Yields
for the overall conversion of the α-aminocycloalkyl cuprate cross-coupling intermediates 28-31
to the final targets 1, 2, 4 ranged from 43-55% for the 3-step process.

52
Chapter 5: Conclusion and Future Direction

Generally, this project will contribute to α-aminoalkyl copper reagent chemistry and the
cuprate method developed may prove beneficial to other THQ natural alkaloid research. The
cuprate method developed can be easily applied to a variety of alkyl iodides and allow for a
myriad of Hancock THQ alkaloid derivatives to be produced. Under the current coronavirus
pandemic circumstances, the antibacterial assay was not completed. Studies into antibacterial
activity of these compounds would be a worthwhile endeavor and should be accomplished. The
synthesis of the Galipeine target was also truncated due to the university closure. Cuprate
coupling was accomplished as well as hydrolysis to the N-formyl derivative (36). The final
reduction step provided a mixture of reduced and demethylated products and due to time
restrictions only one attempt was possible. With more time, this target would have been easily
produced. Further studies into other THQ based alkaloids could also provide new compounds
with antibacterial potential. A broad analysis of cuprate reaction parameters including Cu(I)x
stoichiometric ratio, temperature, and timing would be beneficial in understanding the scope and
limitation of the cuprate reactions.
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Chapter 6: Materials and Methods
6.1 General information
All reactions, unless stated otherwise, were performed in oven dried glassware.
The nitrogen used for experiments was passed through a column of drierite (anhydrous calcium
sulfate). DCE (1,2-dichloroethane) was distilled over CaH2 and stored over 3Å molecular sieves.
Other solvents including DCM (dichloromethane), toluene, diethylether and THF
(tetrahydrofuran) were dispensed from a solvent purification machine as needed. Ethyl acetate,
acetone, and hexane were used directly from purchased stock bottles. Reagents such as
triethylamine, THQ, t-butylamine, and ethyl formate were distilled at atmospheric pressure prior
to use. NBS was recrystallized from water. Reagents such as LAH, (trimethylsilyl chloride
(TMSCl), 1-pentyne, triphenylphosphine, boron trifluoride diethyl etherate, epichlorohydrin, KI,
NaOH, CuSO4, NH4OH, and the alcohol starting materials were used directly from stock bottles.
t-BuLi was used directly from stock bottles and titrated regularly using a procedure by Shapiro42
et al. which utilized 1,3-diphenylacetone p-tosylhydrazone. All TBF intermediates were column
purified using 93:7 hexane:triethylamine with silica gel (230-400 mesh, 60A) followed by
vacuum distillation. All N-formyl intermediates and N-methyl targets were column purified
using 80:20 hexane:ethyl acetate with silica gel (230-400 mesh, 60 Å) followed by reduced
pressure distillation to purify. Reactions were monitored by thin layer chromatography
preformed on aluminum-backed silica coated plates. Visualization of TLC was achieved using a
245 nm UV lamp and stained using KMnO4. Columns chromatography was performed with
silica gel (230-400 mesh, 60 Å) TBF derivatives were not sent for C, H, N elemental
(combustion) analysis due to their instability. Note, kugelrohr distillation is a bulb-to-bulb
distillation method.
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6.2 Instrumentation
13

C, 1H, DEPT-135 and HSQC NMR experiments were performed on the Bruker

Advance III AG 400 MHz spectrometer using deuterochloroform (CDCl3) solvent.
Trimethylsilane (TMS, δ=0 ppm) was used as the internal standard for all NMR analyses.
Chemical shifts are expressed in ppm (δ) chemical shift and splitting are represented as follows,
s = singlet, d = doublet, t - triplet, q = quartet, m = multiplet. IR spectra were obtained using an
ATR method as neat samples using Perkin Elmer spectrometer. Elemental analysis was carried
out by Atlantic Microlab LLC in Norcross, GA.

1,2,3,4-Tetrahydroquinoline was purchased from Oakwood Chemicals and
distilled before use. The liquid was an almost colorless viscous oil after distillation.
¹H NMR (400 MHz, CDCl3): δ 1.95 (m, 2H), 2.76 (t, 2H, J = 6.4 Hz), 3.30 (t, 2H, J = 5.6 Hz),
3.8 (s, 1H), 6.47 (d, 1H), 6.59 (d, 1H), 6.97 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 22.13,
26.92, 41.93, 114.12, 116.87, 121.38, 126.66, 129.45, 144.73.
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Synthesis of 3,4-dihydroquinoline-1(2H)-carbaldehyde.
In an oven dried 200 mL RBF was added p-toluenesulfonic acid (1.43 g, 0.15 eq) and
distilled ethyl formate (75 mL) and the reaction dissolved with stirring. Distilled
tetrahydroquinoline 11 (6.28 mL, 50 mmol) was added and the reaction heated to reflux for 72 h.
The precipitate was filtered off and the ethyl formate removed through atmospheric distillation
and vacuum. The crude oil was purified using column chromatography (50:50 ethyl
acetate:hexane) followed by kugelrohr distillation (92-93 °C at 0.453 torr) to afford 10 in 84%
yield as a bright white crystalline powder.
¹H NMR (400 MHz, CDCl3): δ 1.97 (m, 2H), 2.82 (t, 2H, J = 5.6 Hz), 3.82 (t, 2H, J = 6.0 Hz),
7.08-7.22 (m, 4H), 8.80 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 22.31, 27.16, 40.34, 117.06,
124.58, 127.14, 128.98, 129.66, 137.31, 161.15. (IR) 3061, 2941, 2890, 2840, 1652, 1499, 1252,
763, 752 cm-1.
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Synthesis of N-tert-butyl-1-(3,4-dihydroquinolin-1(2H) yl)methanimine 13 Method A
Synthesis of the TBF functionalized THQ compound began with the synthesis of
Meerwein’s reagent, [(Et3O)+(BF4-)] carried out in an oven dried nitrogen cooled 500 mL 3-neck
RBF fitted with a condenser, addition funnel and addition port, assembled hot. To this was added
boron trifluoride diethyl etherate (8.10 mL, 65.6 mmol) and dry diethyl ether (120 mL). Next,
epichlorohydrin (3.86 mL, 49.2 mmol) was added dropwise over 15 min and the reaction was
heated to reflux for 1 h followed by 24 h at rt with no stirring to allow the crystals to settle. After
the crystals had settled, the ether was removed using a long syringe and the crystals were washed
two times with dry diethyl ether (30 mL) followed by passing dry argon over them to remove
most of the ether solvent. In the same flask, the crystals were dissolved in freshly distilled DCE
(100 mL) followed by the slow addition of N-formyl THQ 10 (6.04 g, 37.5 mmol) dissolved in
dry DCE (20 mL) and the reaction heated to reflux for 24 h. Lastly, the reaction was cooled to 0
o

C (ice-H2O bath) and t-butylamine (4.54 mL, 43.2 mmol) dissolved in DCE (12 mL) was added.

The reaction was heated at reflux for an additional 24 h. The reaction was quenched with DI
water and washed 3 times with aqueous 20% NaOH (100 mL) The aqueous layer was extracted
tree times with 30 mL DCM. The extracts dried over anhydrous Na2SO4, filtered and
concentrated. The crude product was initially purified by column chromatography (93:7
hexane:trimethylamine) and then the isolated TBF 9 was kugelrohr distilled (77-79 °C at 0.453
torr) to afford 9, a colorless liquid in 82% yield. This oil was stored over anhydrous CaCO3 to
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maintain dryness. Both 13C and 1H NMR spectra closely match the reported data from Davies7,12
et al.
¹H NMR (400 MHz, CDCl3): δ 1.25 (s, 9H), 1.92 (m, 2H), 2.75 (t, 2H, J = 6.0 Hz), 3.75 (t, 2H, J
= 6.0 Hz), 6.85 (t, 1H, J = 6.0 Hz), 6.94 (d, 1H, J = 8.0 Hz), 7.06 (d, 1H, J = 7.2 Hz), 7.15 (t, 1H,
J = 8.0 Hz), 8.145 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 22.17, 27.9, 31.2, 43.2, 54.1, 114.7,
120.8, 127.0, 127.2, 129.2, 141.0, 146.9. IR (neat): 3070, 3027, 2962, 2866, 1636, 1602, 1578,
1496, 1194, 1171, 746 cm-1.
Compound 9 Method B
The alternative synthesis for the TBF-THQ 9 compound was a direct trans-amination
process. In an oven dried 50 mL RBF was added NH4SO4 (0.1 g, 0.5 mmol) along with dry
toluene (10 mL) and freshly distilled N, N-dimethyl-N-t-butylformamidine 12 (1.28 mL, 10
mmol) and the reaction stirred for 15 min. Next, tetrahydroquinoline 11 (0.65 mL, 5 mmol) was
added dropwise and the reaction heated at reflux for 48 h. The toluene was removed under
reduced pressure and crude residue was purified by column chromatography (93:7
hexane:trimethylamine) followed by kugelrohr distillation (77-79 oC at 0.453 torr) to afford pure
TBF product 9 as a colorless oil in 30-40% yields.
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Synthesis of 1-iodopentane
In a clean oven dried nitrogen cooled 100 mL RBF was added pentanol (0.731 g, 8.3
mmol) and DCM (50 mL). Once dissolved, triphenylphosphine (3.268 g, 12.5 mmol, 1.5 eq) was
added and the reaction was stirred at rt for 10 min. To this was added recrystallized NBS (2.22 g,
12.5 mmol, 1.5 eq) and the reaction was stirred for 24 h at rt. The reaction mixture was
concentrated under reduced pressure and passed with pressure through 30 g silica using 80:20
hexane:ethyl acetate as the eluent. The solvent was removed under reduced pressure to afford 14
in 73% yield as a colorless oil.
¹H NMR (400 MHz, CDCl3): δ 0.934 (t, 3H, J = 7.2 Hz), 1.31-1.44 (m, 4H), 1.83-1.88 (m, 2H),
3.41 (t, 2H).
This liquid 14 was added to a clean 100 mL RBF dissolved in acetone (50 mL) and
stirred at rt for 10 min. KI (2.49 g, 15 mmol, 2 eq) was added and the reaction heated at reflux
for 24 h. The residual solid was filtered by gravity filtration and the reaction concentrated under
reduced pressure. The residue was passed through 20 g silica with pressure using 80:20
hexane:ethyl acetate as the eluent. The fractions were combined and concentrated under reduced
pressure and the 1-iodiopentane was distilled at atmospheric pressure to afford a colorless oil 18
in 75% yield. The oil was stored in an amber colored vial with a piece of copper wire.
¹H NMR (400 MHz, CDCl3): δ 0.934 (t, 3H, J = 6.8 Hz), 1.32-1.39 (m, 4H), 1.80-1.85 (m, 2H),
3.19 (t, 2H, J = 7.2 Hz).
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Synthesis of 4-(2-iodoethyl)-1,2-dimethoxybenzene
In a clean oven dried nitrogen cooled 100 mL RBF was added 3,4-dimethoxyphenethyl
alcohol (1.51 g, 8.3 mmol) and DCM (50 mL). Once dissolved, triphenylphosphine (3.268 g,
12.5 mmol, 1.5 eq) was added and the reaction stirred for 10 min. To this was added
recrystallized NBS (2.22 g, 12.5 mmol, 1.5 eq) and the mixture was stirred for 24 h at rt. The
reaction mixture was concentrated under reduced pressure and passed with pressure through 30 g
silica using 80:20 hexane:ethyl acetate as the eluent. The solvent was removed in vacuo and the
product crystalized into an off-white solid 15 in 97% yield.
¹H NMR (400 MHz, CDCl3): δ 3.11 (t, 2H, J = 7.6 Hz), 3.55 (t, 2H, J = 8.2 Hz), 3.86 (s, 3H),
3.88 (s, 3H), 6.73-6.84 (m, 3H).
Compound 15 was added to a clean 100 mL RBF and dissolved in acetone (50 mL) with
stirring. To this was added KI (2.49 g, 15 mmol, 2 eq) and the reaction heated to reflux for 24 h.
The residual solid was gravity filtered and the solution concentrated under reduced pressure. The
residue was passed through 20 g silica with pressure using 80:20 hexane:ethyl acetate as the
eluent. The solvent was removed under reduced pressure as the product crystalized to afford a
slightly yellow solid 19 in 93% yield.
¹H NMR (400 MHz, CDCl3): δ 3.12 (t, 2H, J = 8.0 Hz), 3.33 (t, 2H, J = 8.0 Hz), 3.87 (s, 3H),
3.88 (s, 3H), 6.70-6.83 (m, 3H).
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Synthesis of 5-(2-iodoethyl)benzo[d][1,3]dioxole
In a clean oven dried nitrogen cooled 100 mL RBF was added methylenedioxy phenethanol
(1.38 g, 8.3 mmol) and DCM (50 mL). Once dissolved, triphenylphosphine (3.268 g, 12.5 mmol,
1.5 eq) was added and the reaction stirred at rt for 10 min. To this was added recrystallized NBS
(2.22 g, 12.5 mmol, 1.5 eq) and the reaction stirred for 24 h at rt. The reaction was concentrated
under reduced pressure and passed with pressure through 30 g silica using 80:20 hexane:ethyl
acetate as the eluent. The concentrated oil crystalized into an off-white solid under reduced
pressure affording 17 in 97% yield as a white powder.
¹H NMR (400 MHz, CDCl3): δ 3.07 (t, 2H, J = 7.6 Hz), 3.51 (t, 2H, J = 7.6 Hz), 5.94 (s, 2H),
6.65-6.77 (m, 3H).
Product 17 was added to a clean 100 mL RBF and dissolved in acetone (50 mL) for 10 min
with stirring. KI (2.49 g, 15 mmol, 2 eq) was added and the reaction heated to reflux for 24 h.
Residual solids were gravity filtered and the reaction concentrated under reduced pressure. The
crude oil was passed through 20 g silica with pressure using 80:20 hexane:ethyl acetate as the
eluent. The fractions were combined and concentrated under reduced pressure and the product
crystalized to afford 21 in 97% yield as an off-white solid.
¹H NMR (400 MHz, CDCl3): δ 3.08 (t, 2H, J = 7.6 Hz), 3.30 (t, 2H, J = 8.0 Hz), 5.94 (s, 2H),
6.65-6.77 (m, 3H).
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Synthesis of tert-butyl(4-(2-iodoethyl)-2-methoxyphenoxy)dimethylsilane
In a 500 mL RBF fitted with an addition funnel was added KBr (36.2 mmol, 4.31 g), 22
(36.2 mmol, 4.99 g) and acetone (100 mL) sequentially. The reaction cooled to -10 °C in an ice
bath for 10 min. A solution of oxone (33.3 g) in DI water (170 mL) was added dropwise over 30
min and stirred for 24h at rt. The mixture was extracted with ethyl acetate (3x 75 mL), dried over
sodium sulfate and recrystallized from water to afford 23, a pure white solid in 43% yield.
¹H NMR (400 MHz, CDCl3): δ 2.78 (t, 2H, J = 6.4 Hz), 3.83 (t, 2H, J = 6.4 Hz), 5.51 (s, 1H),
6.95-7.09 (m, 2H), 7.34 (1H, s).
In an oven dried pressure tube was added 23 (1.23 g, 10.86 mmol) K2CO3 (5 g, 32.6
mmol, 3 eq), CuCl (0.538 g, 5.43 mmol, 0.5 eq) and dry methanol (10 mL) sequentially. The
mixture was heated in a sealed tube to 125 °C (silicon oil bath) for 48 h. To the reaction mixture
was added 3M HCl until pH ̴ 3. The mixture was filtered through celite, extracted with ethyl
acetate (3x 50 mL), concentrated in vacuo, and purified via column chromatography (100%
diethyl ether) to afford 24 in 40% yields as a yellow oil.
¹H NMR (400 MHz, CDCl3): δ 2.80 (t, 2H, J = 6.4 Hz), 3.84 (t, 2H, J = 6.4 Hz), 3.90 (s, 3H),
5.51 (s, 1H), 6.72-6.88 (m, 3H).
In a 100 mL RBF was added 24 (0.5 g, 2.95 mmol), DCM (50 mL), NBS (0.788 g, 4.43
mmol) and PPh3 (1.16 g, 4.43 mmol) sequentially. The mixture was stirred at rt for 24h. The
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crude mixture was concentrated under reduced pressure and passed through 20 g silica using
80:20 hexane:ethyl acetate as the eluent to afford 25 in 60% yield as a colorless oil.
¹H NMR (400 MHz, CDCl3): δ 3.09 (t, 2H, J = 7.6 Hz), 3.53 (t, 2H), 3.89 (s, 3H), 5.54 (s, 1H),
6.70-6.87 (m, 3H).
In a 50 mL RBF 25 (0.142 g, 0.625 mmol), TBDMS-Cl (0.0942 g, 0.625 mmol),
imidazole (0.021 g, 0.5 eq, 0.310 mmol) and DCM (10 mL) were added sequentially and the
mixture stirred for 24 h at rt. The reaction mixture was washed 3 times with DI water and
extracted with DCM (3x 10 mL). Extracts were dried over Na2SO4, gravity filtered and
concentrated to afford 26 in 60% yields as a slightly yellow oil.
¹H NMR (400 MHz, CDCl3): δ 0.145 (s, 6H), 0.99 (s, 9H), 3.08 (t, 2H, J = 7.6 Hz), 3.53 (t, 2H, J
= 8.0 Hz), 3.80 (s, 3H), 6.64-6.79 (m, 3H).
In a 25 mL RBF 26 (0.085 g, 0.375 mmol), KI (3 eq, 0.200 g) and acetone (8 mL) were
added. The mixture was heated to reflux for 24 h. The crude reaction mixture was filtered,
concentrated and passed through 10 g silica using 80:20 hexane:ethyl acetate as the eluent.
Solvent was removed in vacuo to afford 27 in 83% yield as a slightly yellow oil.
¹H NMR (400 MHz, CDCl3): δ 0.145 (s, 6H), 0.99 (s, 9H), 3.10 (t, 2H, J = 8.0 Hz), 3.32 (t, 2H, J
= 8.0 Hz), 3.80 (s, 3H), 6.62-6.79 (m, 3H).
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Synthesis of 1-pentynyl copper
In a clean 500 mL RBF, CuSO4 (6.24 g, 25 mmol), DI water (150 mL) and
hydroxylamine hydrochloride (3.47 g, 50 mmol) were added sequentially and stirred at rt until
dissolved. Concentrated NH4OH (aq, 25 mL, 25 mmol) was added and the mixture stirred at rt
for 15 min. Next a solution of 95% ethanol (80 mL) and 1-pentyne (2.46 mL, 25 mmol) was
added quickly and the reaction stirred at rt under nitrogen for 2 h. The bright yellow solid was
vacuum filtered and rinsed with ice cold water (100 mL), cold 95% ethanol (50 mL) and diethyl
ether (30 mL) sequentially. The yellow powder was transferred to a vial and dried under reduced
pressure for 48 h. The dry yellow powder, prepared in a 70% yield, was stored under argon.
(IR) 2962, 2933, 2896, 2874, 2818, 2727, 1940, 1902, 1885, 1668, 1464, 1430, 1263, 1097, 873,
732 cm-1.
A typical method for preparing and cross-coupling the α-aminocycloalkyl cuprate with an
alkyl halide
The cuprate synthesis remained consistent regardless of the chosen coupled alkyl halide.
A typical synthesis began with the addition of 9 (0.108 g, 0.5 mmol) to a heat dried nitrogen
cooled 50 mL RBF followed by the addition of dry THF (3 mL). The mixture was cooled to -78
°C for 15 min followed by the addition of 1.59 M t-butyllithium in pentane (0.364 mL, 0.5
mmol) and allowed to stir for 10 min. The reaction was then warmed to -25 °C and stirred for 1
h. The deep red solution was quickly cannulated using positive argon pressure (balloon) to
another dry 50 mL RBF containing 1-pentynyl copper (0.065 g, 0.5 mmol) and dry THF (3 mL)
cooled to -25 °C. The cuprate suspension was warmed to 0 °C for 15 min and allowed to warm
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to rt over 60 min. Once at rt the suspension slowly transitioned to a completely homogenous
yellow/gold solution indicating complete cuprate formation. Once homogenous, the solution was
cooled to -10 °C and 1-iodopentane (0.149 g, 0.75 mmol) dissolved in THF (1 mL) was added
dropwise and the reaction allowed to warm overnight (18 h) The reaction was quenched with DI
water (1 mL), filtered through celite and extracted using 3x 20 mL DCM portions. The DCM
extracts were combined and concentrated to afford the crude oil. The crude oil mixture was
kugelrohr vacuum distilled carefully to allow for fractionation. The first fraction containing the
starting materials came over at or below 120 °C at 0.453 torr. The bulb was switched and heated
to 160 °C at 0.453 torr to distill the coupled compound 30, a slightly yellow viscous oil in 55%
yield.

Synthesis of N-tert-butyl-1-(2-pentyl-3,4-dihydroquinolin-1(2H)yl)methanimine. According to the general procedure N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)yl)methanimine 9 (0.108 g, 0.5mmol), t-buLi (1.49M, 0.364 mL, 0.5 mmol), 1-pentynyl copper
32 (0.065 g, 0.5 mmol) and 1-iodopentane 18 (0.149 g, 0.75 mmol) were combined in an RBF to
furnish 29 (0.079 g, 55%) after distillation (91 °C at 0.453 torr) as a slightly yellow oil.
¹H NMR (400 MHz, CDCl3): δ 0.85 (t, 3H, J = 6.8 Hz), 1.19 (s, 9H), 1.27-1.32 (m, 6H), 1.65 (m,
2H), 1.85 (m, 2H), 2.70-2.84 (m, 2H), 4.78 (m, 1H), 6.85 (t, 1H, J = 7.2 Hz), 6.89 (d, 1H, J = 8.0
Hz), 7.07-7.13 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 14.08, 22.64, 23.58, 25.07, 25.55, 30.90,
31.10, 31.75, 48.90, 53.83, 115.88, 120.76, 126.34, 126.74, 129.45, 140.55, 146.32. (IR) 3027,
2958, 2928, 2858, 1637, 1602, 1578, 1193, 747 cm-1.
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Synthesis of N-tert-butyl-1-(2-(3,4-dimethoxyphenethyl)-3,4dihydroquinolin-1(2H)-yl)methanimine. According to the general procedure N-tert-butyl-1(3,4-dihydroquinolin-1(2H)-yl)methanimine 9 (0.108 g, 0.5 mmol), t-buLi (0.364 mL, 0.5
mmol), 1-pentynyl copper 32 (0.065 g, 0.5 mmol) and 4-(2-iodoethyl)-1,2-dimethoxybenzene 19
(0.207 g, 0.75 mmol) were combined in an RBF to furnish 30 (0.122 g, 64%) after distillation
(160 °C at 0.453 torr) as a slightly yellow viscous oil.
¹H NMR (400 MHz, CDCl3): δ 1.23 (s, 9H), 1.64 (m, 1H), 1.86-1.97 (m, 3H), 2.55-2.83 (m, 4H),
3.83 (s, 3H), 3.85 (s, 3H), 4.85 (m, 1H), 6.67 (s, 1H), 6.75 (s, 1H), 6.89 (t, 1H, J = 7.6 Hz), 6.92
(d, 1H, J = 8.0 Hz), 7.08-7.13 (m, 2H), 8.04 (s, 1H).
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Synthesis of N-tert-butyl-1-(2-(4-((tertbutyldimethylsilyl)oxy)-3-methoxyphenethyl)-3,4-dihydroquinolin-1(2H)-yl)methanimine.
According to the general procedure N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)-yl)methanimine 9
(0.108 g, 0.5 mmol), t-buLi (0.364 mL, 0.5 mmol), 1-pentynyl copper 32 (0.065 g, 0.5 mmol)
and tert-butyl(4-(2-iodoethyl)-2-methoxyphenoxy)dimethylsilane 20 (0.207 g, 0.75 mmol) were
added in a dry RBF to furnish 31 (0.120 g, 50%) after distillation (170 °C at 0.453 torr) as a clear
colorless oil.
¹H NMR (400 MHz, CDCl3): δ 0.119 (s, 6H), 0.973 (s, 9H), 1.23 (s, 9H), 1.79-1.99 (m, 4H),
2.54-2.72 (m, 2H), 3.74 (s, 3H), 4.85 (m, 1H), 6.61 (t, 1H, J = 8.4 Hz), 6.63 (s, 1H), 6.70 (d, 1H,
J = 6.8 Hz), 6.89 (t, 1H), 6.98 (d, 1H, J = 8.0 Hz), 7.08-7.26 (m, 3H), 8.04 (s, 1H).
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Synthesis of 1-(2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4dihydroquinolin-1(2H)-yl)-N-(tert-butyl)methanimine. According to the procedure above, Ntert-butyl-1-(3,4-dihydroquinolin-1(2H)-yl)methanimine 9 (0.108 g, 0.5 mmol) t-buLi, (1.59 M,
0.364 mL, 0.5 mmol) 1-pentynyl copper, 32 (0.065 g, 0.5 mmol) and 5-(2iodoethyl)benzo[d][1,3]dioxole 21 (0.207 g, 0.75 mmol) were combined in an RBF to furnish 28
(0.109 g, 60%) after distillation (160 °C at 0.453 torr) as a clear colorless oil
¹H NMR (400 MHz, CDCl3): δ 1.23 (s, 9H), 1.64 (m, 2H), 1.82-1.96 (m, 3H), 2.52-2.84 (m, 4H),
4.83 (m, 1H), 5.88 (s, 2H), 6.65 (t, 2H), 6.74 (s, 1H), 6.89 (t, 1H, J = 7.6 Hz), 6.95 (d, 1H, J =
8.0 Hz), 7.07-7.15 (m, 2H), 8.04 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 23.63, 25.51, 31.11,
31.99, 33.23, 48.77, 53.92, 100.64, 107.93, 109.1, 116.19, 121.04, 121.13, 126.45, 126.83,
129.39, 136.36, 140.41, 145.38, 146.49, 147.36.
General Method for the hydrolysis of t-butyl formamidines
The TBF compounds 28-31 were transferred to a 50 mL RBF using DCM. DI water (20
mL) was added and the reaction heated to reflux for 24 h. The reaction mixture was extracted
with 3x 20 mL DCM portions. The extracts were combined and concentrated under reduced
pressure. The crude N-formyl product was purified by column chromatography (80:20
hexane:ethyl acetate) followed by kugelrohr distillation to afford pure N-formyl targets 34-37 as
colorless oils with a boiling range from 120-180 °C at 0.453 torr.
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Synthesis of 2-pentyl-3,4-dihydroquinoline-1(2H)carbaldehyde. According to the general procedure, the corresponding TBF compound 29 (0.079
g, .028 mmol) and DI water (10 mL) were added and heated to reflux for 24 h. After column
chromatography (50:50 hexane:ethyl acetate) and distillation (150 °C at 0.453 torr) Compound
34 was prepared as a slightly yellow liquid (0.075 g, 95%).
¹H NMR (400 MHz, CDCl3): δ 0.85 (t, 3H), 1.25-1.49 (m, 8H), 1.50 (m, 2H), 1.82 (m, 1H), 2.05
(m, 1H), 2.72-2.86 (m, 2H), 4.75 (m, 1H), 7.1-7.26 (m, 4H), 8.69 (s, 1H). 13C NMR (100 MHz,
CDCl3): δ 14.01, 22.54, 23.69, 25.58, 26.56, 31.33, 31.64, 48.41 118.61, 124.85, 127.12, 129.26,
129.43, 136.39, 161.43. IR (neat): 3041, 2952, 2928, 2858, 1668, 1582, 1496, 1244, 754, 675
cm-1.
Anal. Calculated for C15H21NO: C, 77.88; H, 9.15, N, 6.05. Found: C, 78.02, H, 9.27, N, 6.07.
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Synthesis of 2-(3,4-dimethoxyphenethyl)-3,4dihydroquinoline-1(2H)-carbaldehyde. According to the general procedure, the corresponding
TBF compound 30 (0.122 g, .032 mmol) and DI water (10 mL) was heated to reflux for 24 h.
After column chromatography (50:50 hexane:ethyl acetate) and distillation (150 °C at 0.453 torr)
Compound 35 was prepared as a slightly yellow liquid (0.116 g, 95%).
¹H NMR (400 MHz, CDCl3): δ 1.70-1.93 (m, 4H), 2.56-2.85 (m, 4H), 3.83 (s, 3H), 3.84 (s, 3H),
4.85 (m, 1H), 6.66 (d, 1H, J = 7.2 Hz), 6.68 (s, 1H), 6.74 (d, 1H, J = 8.0 Hz), 7.06-7.26 (m, 4H),
8.69 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 23.15, 26.35, 31.36, 32.77, 47.67, 55.30, 55.41,
110.62, 111.19, 118.24, 119.54, 124.49, 126.67, 128.62, 128.95, 133.62, 135.69, 146.67, 148.23,
161.06. IR (neat): 3067, 3037, 2998, 2932, 2860, 2834, 1665, 1514, 1496, 1258, 1027, 756 cm-1.
Anal. Calculated for C20H23NO3: C, 73.82; H, 7.12, N, 4.30. Found: C, 73.7, H, 7.18, N, 4.36.
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Synthesis of 2-(4-((tert-butyldimethylsilyl)oxy)-3methoxyphenethyl)-3,4-dihydroquinoline-1(2H)-carbaldehyde. According to the general
procedure, the corresponding TBF compound 31 (0.120 g, .025 mmol) and DI water (10 mL)
were heated to reflux for 24 h. After column chromatography (50:50 hexane:ethyl acetate) and
distillation (150 oC at 0.453 torr) Compound 36 was prepared as a viscous slightly yellow liquid
(0.114 g, 95%).
¹H NMR (400 MHz, CDCl3): δ 0.12 (s, 6H), 0.98 (s, 9H), 1.73-2.08 (m, 4H), 2.54-2.86 (m, 4H),
3.75 (s, 3H), 4.84 (m, 1H), 6.56 (d, 1H), 6.64 (s, 1H), 6.71 (d, 1H, J = 8.0 Hz), 7.06-7.26 (s, 4H),
8.69 (s, 1H).
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Synthesis of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4dihydroquinoline-1(2H)-carbaldehyde. According to the general procedure, the corresponding
TBF compound 28 (0.109 g, .030 mmol) and DI water (10 mL) were heated to reflux for 24 h.
After column chromatography (50:50 hexane:ethyl acetate) and distillation (150 °C at 0.453 torr)
Compound 37 was prepared as a viscous slightly yellow liquid (0.100 g, 95%).
¹H NMR (400 MHz, CDCl3): δ 1.65 (m, 1H), 1.84 (m, 2H), 2.03 (m, 2H), 2.49-2.82 (m, 4H),
4.82 (m, 1H), 5.83 (s, 2H), 6.64 (m, 2H), 6.64 (d, 1H, J = 7.6 Hz), 7.06-7.18 (m, 4H), 8.68 (s,
1H). 13C NMR (100 MHz, CDCl3): δ 23.61, 26.76, 31.84, 33.52, 48.05, 100.76, 108.1, 108.81,
118.67, 121.05, 124.99, 126.41, 128.99, 129.51, 135.38, 136.18, 145.67, 147.54, 161.49. Anal.
IR (neat): 3067, 3031, 2927, 2893, 2860, 2779, 1664, 1488, 1240, 1035, 927, 755 cm-1.
Calculated for C19H19NO3: C, 73.77; H, 6.19, N, 4.53. Found: C, 73.68, H, 6.23, N, 4.56.
6.8 General Procedure for Reduction of N-formyl alkaloids
In a clean oven dried nitrogen cooled 25 mL RBF was added lithium aluminum hydride
(LAH, 0.045 g, 1.2 mmol) and dry THF (3 mL). To this was added a solution of 37 (0.175 g,
0.55 mmol) and the reaction was heated to reflux for 24 h. The reaction was quenched with DI
water dropwise and 20% NaOH (aq). The precipitate was filtered through celite and aqueous
layer extracted 3 times with DCM (20 mL). DCM extracts were combined and concentrated
under reduced pressure. The crude mixture was purified by column chromatography (50:50
hexane:ethyl acetate) followed by vacuum kugelrohr distillation to afford pure 4 in 85% yield as
a colorless viscous oil.
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Synthesis of 1-methyl-2-pentyl-1,2,3,4-tetrahydroquinoline.
According to the general procedure, the corresponding N-formyl compound 34 (0.075 g, 0.035
mmol) and dry THF (3 mL) were added followed by LAH (0.040 g, 5 eq, 0.132 mmol) and the
mixture heated to reflux for 24 h. After column chromatography (50:50 hexane:ethyl acetate) and
distillation (90 °C at 0.453 torr) compound 1 was prepared (0.060 g, 85%) as a clear colorless
oil. Both 13C and 1H NMR spectra closely match the reported data from Davies7,12 et al.
¹H NMR (
400 MHz, CDCl3): δ 0.88 (t, 3H, J = 7.2 Hz), 1.25-1.32 (m, 8H), 1.88 (m, 2H), 2.66-2.88 (m,
2H), 2.92 (s, 3H), 3.23 (m, 1H), 6.52 (d, 1H, J = 8.4 Hz), 6.57 (t, 1H, J = 7.2 Hz), 6.95 (d, 1H, J
= 7.2 Hz), 7.07 (t, 1H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ 14.05, 22.67, 23.54, 24.36,
25.74, 31.15, 32.03, 37.95, 58.92, 110.35, 115.13, 121.81, 127.03, 128.61, 145.37. IR (neat):
3067, 3021, 2952, 2926, 2867, 2856, 2795, 1602, 1498, 1214, 741, 717 cm-1.
Anal. Calculated for C15H23N: C, 82.89; H, 10.67, N, 6.44. Found: C, 82.97, H, 10.65, N, 6.29.
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Synthesis of 2-(3,4-dimethoxyphenethyl)-1-methyl-1,2,3,4tetrahydroquinoline. According to the general procedure, of the corresponding N-formyl
compound 35 (0.116 g, 0.0373 mmol) and dry THF (0.116 g) were added followed by LAH
(0.050 g, 5 eq, 0.132 mmol) and the mixture heated to reflux for 24 h. After column
chromatography (50:50 hexane:ethyl acetate) and distillation (120 °C at 0.453 torr) Compound 2
was prepared (0.098 g, 85%) as a colorless oil. Both 13C and 1H NMR spectra closely match the
reported data from Davies7,12 et al.
¹H NMR (400 MHz, CDCl3): δ 1.73 (m, 1H), 1.92-1.96 (m, 3H), 2.66-2.89 (m, 4H), 2.92 (s, 3H),
3.29 (m, 1H), 3.86 (s, 3H), 3.87 (s, 3H), 6.52 (d, 1H, J = 8.0 Hz), 6.57 (t, 1H, J = 6.8 Hz), 6.71
(m, 2H), 6.80 (d, 1H, J = 8.0 Hz), 6.99 (d, 1H, J = 7.6 Hz), 7.08 (t, 1H, J = 7.6 Hz). 13C NMR
(100 MHz, CDCl3): δ 23.55, 24.34, 31.92, 33.05, 38.11, 55.86, 55.92, 58.41, 110.58, 111.20,
111.50, 115.36, 120.03, 121.70, 127.12, 128.7, 134.62, 145.00, 147.17, 148.85. IR (neat): 3063,
2998, 2932, 2864, 2832, 2798, 1601, 1514, 1498, 1259, 1027, 743 cm-1.
Anal. Calculated for C20H25NO2: C, 77.14; H, 8.09, N, 4.50. Found: C, 77.17, H, 8.06, N, 4.43.
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Synthesis of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-1-methyl1,2,3,4-tetrahydroquinoline. According to the general procedure, the corresponding N-formyl
compound 37 (0.100 g, 0.0339 mmol) and dry THF (3 mL) were added followed by LAH (0.050
g, 5 eq, 0.132 mmol) and he mixture heated to reflux for 24 h. After column chromatography
(50:50 hexane:ethyl acetate) and distillation (120 °C at 0.453 torr) Compound 4 was prepared
(0.085 g, 85%) as a colorless oil. Both 13C and 1H NMR spectra closely match the reported data
from Davies7,12 et al.
¹H NMR (400 MHz, CDCl3): δ 1.69 (m, 1H), 1.71-1.95 (m, 3H), 2.49-2.70 (m, 4H), 2.90 (s, 3H),
3.27 (m, 1H), 5.91 (s, 2H), 6.53 (d, 1H, J = 8.4 Hz), 6.57-6.62 (m, 2H), 6.64 (s, 1H), 6.73 (d,
1H), 6.96 (d, 1H, J = 7.2 Hz), 7.07 (t, 1H, J = 6.0 Hz). 13C NMR (100 MHz, CDCl3): δ 23.55,
24.36, 32.04, 33.15, 38.07, 58.21, 100.8, 108.18, 108.73, 110.62, 115.42, 120.96, 121.72, 127.13,
128.69, 135.86 145.3, 145.6, 147.62. IR (neat): 3067, 3019, 2930, 2889, 2795, 1601, 1499, 1488,
1241, 1036, 743 cm-1.
Anal. Calculated for C19H21NO2: C, 77.26; H, 7.17, N, 4.74. Found: C, 77.56, H, 7.44, N, 4.72.
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7.0 NMR Spectra
7.1 1H NMR spectrum of 1,2,3,4-tetrahydroquinoline
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7.2

13

C NMR spectrum of 1,2,3,4-tetrahydroquinoline
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7.3 1H NMR spectrum of 3,4-dihydroquinoline-1(2H)-carbaldehyde
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7.4

13

C NMR spectrum 3,4-dihydroquinoline-1(2H)-carbaldehyde
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7.5

13

C DEPT-135 NMR spectrum of 3,4-dihydroquinoline-1(2H)-carbaldehyde
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7.6 1H-13C HSQC NMR spectrum of 3,4-dihydroquinoline-1(2H)-carbaldehyde

81
7.7 IR spectrum of 3,4-dihydroquinoline-1(2H)-carbaldehyde

82
7.8 1H NMR spectrum of N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)-yl)methanimine.

83
7.9 13C NMR spectrum of N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)-yl)methanimine.
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7.10 13C DEPT-135 NMR spectrum of N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)yl)methanimine.
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7.11 1H-13C HSQC NMR spectrum of N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)yl)methanimine.

86
7.12 IR spectrum of N-tert-butyl-1-(3,4-dihydroquinolin-1(2H)-yl)methanimine.
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7.13 1H NMR spectrum of pentanol

88
7.14 1H NMR spectrum of Bromopentane

89
7.15 1H NMR spectrum of 1-iodopentane

90
7.16 1H NMR spectrum of Dimethoxyphenethanol

91
7.17 1H NMR spectrum of 4-(2-bromoethyl)-1,2-dimethoxybenzene

92
7.18 1H NMR spectrum of 4-(2-iodoethyl)-1,2-dimethoxybenzene

93
7.19 1H NMR spectrum of tert-butyl(4-(2-iodoethyl)-2-methoxyphenoxy)dimethylsilane

94
7.20 1H NMR spectrum of (4-(2-bromoethyl)-2-methoxyphenoxy)(tert-butyl)dimethylsilane

95
7.21 1H NMR spectrum of 4-(2-bromoethyl)-2-methoxyphenol

96
7.22 1H NMR spectrum of 4-(2-hydroxyethyl)-2-methoxyphenol

97
7.23 1H NMR spectrum of 2-bromo-4-(2-hydroxyethyl)phenol

98
7.24 1H NMR spectrum of 3,4-methylenedioxyphenethanol

99
7.25 1H NMR spectrum of 5-(2-bromoethyl)benzo[d][1,3]dioxole

100
7.26 1H NMR spectrum of 5-(2-iodoethyl)benzo[d][1,3]dioxole

101
7.27 1H NMR spectrum of N-tert-butyl-1-(2-pentyl-3,4-dihydroquinolin-1(2H)yl)methanimine.
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7.28

13

C NMR spectrum of N-tert-butyl-1-(2-pentyl-3,4-dihydroquinolin-1(2H)-

yl)methanimine.
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7.29 13C DEPT-135 NMR spectrum of N-tert-butyl-1-(2-pentyl-3,4-dihydroquinolin-1(2H)yl)methanimine.
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7.30 1H-13C HSQC NMR spectrum of N-tert-butyl-1-(2-pentyl-3,4-dihydroquinolin-1(2H)yl)methanimine.

105
7.31 IR spectrum of N-tert-butyl-1-(2-pentyl-3,4-dihydroquinolin-1(2H)-yl)methanimine.

106
7.32 1H NMR spectrum of N-tert-butyl-1-(2-(3,4-dimethoxyphenethyl)-3,4-dihydroquinolin1(2H)-yl)methanimine

107
7.33 1H NMR spectrum of N-tert-butyl-1-(2-(4-((tert-butyldimethylsilyl)oxy)-3methoxyphenethyl)-3,4-dihydroquinolin-1(2H)-yl)methanimine.

108
7.34 1H NMR spectrum of 1-(2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4-dihydroquinolin1(2H)-yl)-N-(tert-butyl)methanimine.

109
7.35 13C NMR spectrum of 1-(2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4-dihydroquinolin1(2H)-yl)-N-(tert-butyl)methanimine.

110
7.36 13C DEPT-135 NMR spectrum of 1-(2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4dihydroquinolin-1(2H)-yl)-N-(tert-butyl)methanimine.

111

7.37 1H-13C HSQC NMR spectrum of 1-(2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4dihydroquinolin-1(2H)-yl)-N-(tert-butyl)methanimine.

112
7.38 1H NMR spectrum of 2-pentyl-3,4-dihydroquinoline-1(2H)-carbaldehyde.

113
7.39 13C NMR spectrum 2-pentyl-3,4-dihydroquinoline-1(2H)-carbaldehyde.

114
7.40 13C DEPT-135 NMR spectrum of 2-pentyl-3,4-dihydroquinoline-1(2H)-carbaldehyde.
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7.41 1H-13C HSQC NMR spectrum of 2-pentyl-3,4-dihydroquinoline-1(2H)-carbaldehyde.

116
7.42 IR spectrum of 2-pentyl-3,4-dihydroquinoline-1(2H)-carbaldehyde.

117
7.43 1H NMR spectrum of 2-(3,4-dimethoxyphenethyl)-3,4-dihydroquinoline-1(2H)carbaldehyde

118
7.44 13C NMR spectrum of 2-(3,4-dimethoxyphenethyl)-3,4-dihydroquinoline-1(2H)carbaldehyde

119
7.45 13C DEPT-135 NMR spectrum of 2-(3,4-dimethoxyphenethyl)-3,4-dihydroquinoline1(2H)-carbaldehyde

120

7.46 1H-13C HSQC NMR spectrum of 2-(3,4-dimethoxyphenethyl)-3,4dihydroquinoline-1(2H)-carbaldehyde

121
7.47 IR spectrum of 2-(3,4-dimethoxyphenethyl)-3,4-dihydroquinoline-1(2H)carbaldehyde

122
7.48 1H NMR spectrum of 2-(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenethyl)-3,4dihydroquinoline-1(2H)-carbaldehyde.

123
7.49 1H NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4-dihydroquinoline1(2H)-carbaldehyde

124
7.50 13C NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4-dihydroquinoline1(2H)-carbaldehyde

125
7.51 13C DEPT-135 NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4dihydroquinoline-1(2H)-carbaldehyde

126
7.52 IR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-3,4 dihydroquinoline-1(2H)carbaldehyde

127
7.53 1H NMR spectrum of 1-methyl-2-pentyl-1,2,3,4-tetrahydroquinoline.

128
7.54 13C NMR spectrum of 1-methyl-2-pentyl-1,2,3,4-tetrahydroquinoline.

129
7.55 13C DEPT-135 NMR spectrum of1-methyl-2-pentyl-1,2,3,4-tetrahydroquinoline.
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7.56 1H-13C HSQC NMR spectrum of 1-methyl-2-pentyl-1,2,3,4-tetrahydroquinoline.

131
7.57 IR spectrum of 1-methyl-2-pentyl-1,2,3,4-tetrahydroquinoline.

132
7.58 1H NMR spectrum of 2-(3,4-dimethoxyphenethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

133
7.59 13C NMR spectrum 2-(3,4-dimethoxyphenethyl)-1-methyl-1,2,3,4-tetrahydroquinoline.

134
7.60 13C DEPT-135 NMR spectrum of 2-(3,4-dimethoxyphenethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

135

7.61 1H-13C HSQC NMR spectrum of 2-(3,4-dimethoxyphenethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

136
7.62 IR spectrum of 2-(3,4-dimethoxyphenethyl)-1-methyl-1,2,3,4-tetrahydroquinoline.

137
7.63 1H NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

138
7.64 13C NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

139
7.65 13C DEPT-135 NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-1-methyl1,2,3,4-tetrahydroquinoline.

140
.

7.66 1H-13C HSQC NMR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

141
7.67 IR spectrum of 2-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-1-methyl-1,2,3,4tetrahydroquinoline.

142
7.68 IR spectrum of 1-pentynyl copper
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Postface
In light of the 2019 SARS-CoV-2 pandemic, Kennesaw State University was closed to all
on-campus activities which included research laboratories. Therefore, the thesis project was
impacted, and some project goals were not accomplished. This included a) final spectroscopic
characterization of some of the synthetic intermediates b) preparation of starting materials
required for completing the final alkaloid Galipeine and c) the zone of inhibition assay to screen
for the potential antibiotic activity of the alkaloid targets and synthetic intermediates. Because of
the pandemic, the university closure was unfortunate and came at a pivotal time in the project.
With approximately two more weeks of experimental work, project goals could have been
accomplished.
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